Danaher Co. (NYSE:DHR) to Post Q1 2024 Earnings of $1.72 Per Share, Zacks Research Forecasts

Danaher Co. (NYSE:DHR) – Research analysts at Zacks Research lowered their Q1 2024 earnings per share estimates for Danaher in a research note issued to investors on Wednesday, April 17th. Zacks Research analyst R. Department now expects that the conglomerate will post earnings per share of $1.72 for the quarter, down from their previous estimate of $1.74. The consensus estimate for Danaher’s current full-year earnings is $7.62 per share. Zacks Research also issued estimates for Danaher’s Q2 2024 earnings at $1.62 EPS, Q3 2024 earnings at $1.90 EPS, Q4 2024 earnings at $2.34 EPS, Q3 2025 earnings at $2.14 EPS, Q4 2025 earnings at $2.42 EPS, FY2025 earnings at $8.47 EPS, Q1 2026 earnings at $2.25 EPS and FY2026 earnings at $10.01 EPS.

Several other equities analysts also recently weighed in on DHR. Royal Bank of Canada raised their price target on Danaher from $254.00 to $282.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 31st. Citigroup lifted their price objective on Danaher from $255.00 to $280.00 and gave the company a “buy” rating in a research report on Wednesday, January 31st. StockNews.com downgraded Danaher from a “buy” rating to a “hold” rating in a research report on Wednesday, January 31st. Raymond James lifted their price objective on Danaher from $240.00 to $270.00 and gave the company an “outperform” rating in a research report on Wednesday, January 31st. Finally, JPMorgan Chase & Co. lifted their price objective on Danaher from $250.00 to $270.00 and gave the company an “overweight” rating in a research report on Wednesday, December 20th. Six investment analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $268.27.

Danaher Stock Performance

Danaher stock opened at $239.39 on Thursday. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.37 and a current ratio of 1.68. The stock has a fifty day moving average of $249.28 and a two-hundred day moving average of $229.86. The company has a market capitalization of $177.28 billion, a price-to-earnings ratio of 37.46, a PEG ratio of 3.64 and a beta of 0.83. Danaher has a fifty-two week low of $182.09 and a fifty-two week high of $259.00.

Danaher (NYSE:DHR) last released its quarterly earnings results on Tuesday, January 30th. The conglomerate reported $2.09 earnings per share for the quarter, topping the consensus estimate of $1.91 by $0.18. The company had revenue of $6.41 billion during the quarter, compared to the consensus estimate of $6.10 billion. Danaher had a return on equity of 12.25% and a net margin of 17.26%. Danaher’s revenue was down 10.2% compared to the same quarter last year. During the same quarter last year, the business posted $2.87 earnings per share.

Danaher Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, April 26th. Shareholders of record on Thursday, March 28th will be given a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a yield of 0.45%. The ex-dividend date is Wednesday, March 27th. This is an increase from Danaher’s previous quarterly dividend of $0.24. Danaher’s payout ratio is 16.90%.

Insider Buying and Selling at Danaher

In other Danaher news, Director Walter G. Lohr sold 3,289 shares of the business’s stock in a transaction dated Thursday, February 15th. The stock was sold at an average price of $251.15, for a total transaction of $826,032.35. Following the completion of the sale, the director now owns 14,129 shares of the company’s stock, valued at $3,548,498.35. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. In other Danaher news, Director Walter G. Lohr sold 3,289 shares of the business’s stock in a transaction dated Thursday, February 15th. The stock was sold at an average price of $251.15, for a total transaction of $826,032.35. Following the transaction, the director now owns 14,129 shares in the company, valued at $3,548,498.35. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, SVP Daniel Raskas sold 23,757 shares of the business’s stock in a transaction dated Monday, February 26th. The stock was sold at an average price of $252.00, for a total value of $5,986,764.00. Following the transaction, the senior vice president now owns 38,102 shares in the company, valued at approximately $9,601,704. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 32,957 shares of company stock valued at $8,265,802. Company insiders own 10.90% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Buckingham Strategic Partners LLC lifted its stake in shares of Danaher by 1.3% during the fourth quarter. Buckingham Strategic Partners LLC now owns 3,050 shares of the conglomerate’s stock worth $706,000 after purchasing an additional 40 shares in the last quarter. ST Germain D J Co. Inc. lifted its stake in shares of Danaher by 1.4% in the first quarter. ST Germain D J Co. Inc. now owns 2,880 shares of the conglomerate’s stock worth $719,000 after acquiring an additional 41 shares in the last quarter. Nicholas Hoffman & Company LLC. lifted its stake in shares of Danaher by 2.3% in the fourth quarter. Nicholas Hoffman & Company LLC. now owns 1,899 shares of the conglomerate’s stock worth $439,000 after acquiring an additional 43 shares in the last quarter. Berger Financial Group Inc lifted its stake in shares of Danaher by 1.7% in the fourth quarter. Berger Financial Group Inc now owns 2,517 shares of the conglomerate’s stock worth $582,000 after acquiring an additional 43 shares in the last quarter. Finally, Los Angeles Capital Management LLC lifted its stake in shares of Danaher by 1.3% in the fourth quarter. Los Angeles Capital Management LLC now owns 3,470 shares of the conglomerate’s stock worth $803,000 after acquiring an additional 43 shares in the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.